TRCT
BNTC icon

Tower Research Capital (TRC)’s Benitec Biopharma BNTC Stock Holding History

Tower Research Capital (TRC)’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.5K Buy
3,056
+2,333
+323% +$27K ﹤0.01% 3113
2025
Q4 		$9.74K Sell
723
-357
-33% -$4.94K ﹤0.01% 3875
2025
Q3 		$15.2K Buy
1,080
+635
+143% +$8.1K ﹤0.01% 3557
2025
Q2 		$5.21K Buy
+445
New +$6.23K ﹤0.01% 4215
2025
Q1 		– Sell
-1,099
Closed -$13.9K – 5223
2024
Q4 		$13.9K Buy
1,099
+869
+378% +$9.38K ﹤0.01% 3497
2024
Q3 		$2.11K Sell
230
-661
-74% -$5.91K ﹤0.01% 5051
2024
Q2 		$6.23K Sell
891
-854
-49% -$6.3K ﹤0.01% 4604
2024
Q1 		$9.16K Sell
1,745
-750
-30% -$2.88K ﹤0.01% 3885
2023
Q4 		$8.06K Buy
2,495
+2,299
+1,173% +$7.67K ﹤0.01% 4551
2023
Q3 		$592 Sell
196
-243
-55% -$755 ﹤0.01% 5527
2023
Q2 		$1.78K Sell
439
-6
-1% -$23 ﹤0.01% 5321
2023
Q1 		$2K Hold
445
– – ﹤0.01% 5315
2022
Q4 		$1K Sell
445
-11
-2% -$37 ﹤0.01% 5555
2022
Q3 		$3K Buy
456
+230
+102% +$2.92K ﹤0.01% 5366
2022
Q2 		$4K Buy
226
+132
+140% +$3.07K ﹤0.01% 5172
2022
Q1 		$4K Buy
+94
New +$3.9K ﹤0.01% 5181
2021
Q2 		– Sell
-8
Closed -$1K – 5479
2021
Q1 		$1K Buy
+8
New +$544 ﹤0.01% 5146
2016
Q4 		– Sell
-4
Closed -$1K – 3831
2016
Q3 		$1K Hold
4
– – ﹤0.01% 3260
2016
Q2 		$1K Sell
4
-1
-20% -$396 ﹤0.01% 4122
2016
Q1 		$2K Buy
+5
New +$3.67K ﹤0.01% 3332

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Tower Research Capital (TRC)'s BNTC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Benitec Biopharma (BNTC) stake by 323% in Q1 2026, buying an estimated $27K and bringing the position to 3,056 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3113.

Tower Research Capital (TRC) first reported a position in BNTC in Q1 2016 and has held it in 20 quarters since. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Tower Research Capital (TRC) held 3,056 shares of Benitec Biopharma worth $32.5K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,333 Benitec Biopharma shares in Q1 2026, an estimated $27K.
  • Benitec Biopharma made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3113 holding.
  • Tower Research Capital (TRC) first reported a position in Benitec Biopharma in Q1 2016 and has held it in 20 quarters since.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.